Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharma > A.25 > Flashcards

A.25 Flashcards

1
Q

Antipsychotic

A
  1. 1st generation antipsychotic: Haloperidol, Droperidol, Tiapride
  2. 2nd generation antipsychotics: Clozapine, Olanzapine, Quetiapine, Risperidone, Aripiprazole, Cariprazine,
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Psychosis

A

loss of reality control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Types of psychosis

A

Schizophrenia, Affective psychosis, other psychoses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ntipsychotics and DA receptors

A
  1. D1-like family (D1, D5), Gs-coupled
    activation results in ↑adenylyl cyclase activity, ↑cAMP
  2. D2-like family (D2, D3, D4), Gi-coupled
    stimulation results in ↓adenylyl cyclase activity, ↓cAMP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Haloperidol

A

MOA: high selectivity for D2-R antagonism, weak binding to D1, 5-HT, α1, M-ACh-R;
ROA: i.m;
IND: management of acute psychotic disorders→ acute delirium, severe vomiting, hiccups;
Extra: good effect on + symptoms, no effect on - symptoms of schizophrenia, most widely used typical antipsychotic with EPS with high clinical potency;
SEs: EPS (dystonia, akathisia, parkinsonism, tardive dyskinesia), neuroleptic malignant syndrome, hyperprolactinemia, dry mouth, weight gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Droperidol

A

MOA: D2>α1, H1;
Effect: has sedative effect;
IND: used in neuroleptanalgesia (together with fentanyl);
SEs: EPS, NMS, ↑Prolactin, dry mouth, weight gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Clozapine

A

MOA: high affinity antagonist for 5-HT2A/C, M-AChR, adrenergic Rs, weak D2 antagonist;
IND: schizophrenic patients resistant to 1st generation antipsychotics, bipolar disorders;
SEs: seizures (rare), no EPS, Sedation, neuroleptic malignant syndrome, hyperprolactinemia, Cardiomyopathy, blood disorders, Agranulocytosis, QT↑, increased salivation, weight gain, metabolic effects (hyperlipidemia/↓glucose tolerance);
Extra: have effect on + and - symptoms, Dibenzepine structure, medium clinical potency, All antipsychotic decrease the seizure threshold - proconvulsive effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Olanzapine

A

MOA: 5-HT2A/C>D2, M, H1, α1 antagonist→ improves negative symptoms;
Effect: pronounced action on mesolumbic system;
IND: 1st drug of choice in schizophrenia, also proven to be anti-maniac and have good mood stabilizing effect, bipolar disorders, unipolar depression (adjunctive therapy), Acute psychosis;
SEs: small EPS, Sedation, Weight gain, ↑QT interval, ↑Prolactin secretion ;
Extra: have effect on + and - symptoms, Dibenzepine structure, high clinical potency, All antipsychotic decrease the seizure threshold - proconvulsive effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Risperidone

A

MOA: 5-HT2A/C ,D2, H1,α1,2 antagonist→ improves negative symptoms;
IND: acute and chronic schizophrenia, Tics of Tourette disorder in children;
SEs: EPS (dose related), hyperprolacinemia, modest weight gain and metabolic disorders, ↑QT interval; Extra: have effect on + and - symptoms, Benzisoxazole analog, high potency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Aripiprazole

A

MOA: 5-HT2A antagonist→ improves negative symptoms, 5HT1A and D2 partial agonist;
IND: Schizophrenia, bipolar disorders (adunctive therapy), major depressive disorder;
DOA: long acting, T1/2 up to 3 days;
SEs: small EPS, weight gain, akathisia, insomnia;
Extra: have effect on + and - symptoms, Dihydrocabostyril structure, high clinical potency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Quetiapine

A

MOA: 5-HT2A-R>D2 antagonist (lower affinity for D2); IND: schizophrenia, bipolar disorders, unipolar depression;
SEs: sedation, weight gain, low EPS, ↑QT interval;
Extra: have effect on + and - symptoms, Dibenzepines (tricyclic structure), low potency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Tiapride

A

MOA: atypical antipsychotic, D2/3 antagonist;
IND: management of alcohol psychosis, choreoathetoid movements (Tradiv dyskinesia);
Extra: have effect on + and - symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Cariprazine

A

MOA: D3>D2 partial agonist»»5-HT2A/C inverse agonist, 5-HT7 antagonist, partial agonist of 5-HT1A; IND: Schizophrenia, bipolar disorders;
Extra: have effect on + and - symptoms, new Hungarian dicovery (!)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

EPS (Extra Pyramidal Symptoms)

A

Dystonias (minutes),
Drug-induced parkinsonism,
Akathisia (days),
Neuroleptic malignant syndrome (NMS),
peiroral tremor,
lip smacking,
Tradive dyskinesia (weeks)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Endocrine symptoms:

A

Hyperprolactinemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Tardive dyskinesia (TD)

A

a movement disorder that causes a range of repetitive muscle movements in the face, neck, arms and legs. TD symptoms are beyond a person’s control.

17
Q

Akathisia

A

an inability to remain physically still.

18
Q

Neuroleptanalgesia

A

the combination of a potent sedative analgesic agent (an opioid) and a tranquillizer

19
Q

DA pathways in the brain and their function

A
  1. The nigrostriatal DA pathway: part of the extrapyramidal nervous system and controls motor functions
  2. The mesolimbic DA pathway: Delusions and hallucinations
  3. The mesocortical DA pathway: cognitive symptoms and affective symptoms of schizophrenia
  4. Tuberoinfundibular DA pathway: controls prolactin secretion
  5. The fifth DA pathway is from multiple sites, its function is unknown
20
Q

The dopamine hypothesis

A

Amphetamines and L-DOPA can trigger psychosis

21
Q

treatment for Dystonias induced by AP

A

Antihistamines

22
Q

Which antipsychotic can cause Akathisia with high frequency?

A

Aripiprazole
Treatment: BDZs

23
Q

most likely cause of Tradiv dyskinesia

A

upregulation of D2 receptors
Treatment: ↑dose of AP or give another D2 antagonist (e.g. Tiapride)

24
Q

treatment for NMS (neuroleptic malignant syndrome)

A

stop the AP, give bromocryptine (DA agonist), stabilize BP, cool the patient, give BDZs

25
Q

treatment for hyperprolactinemia

A

stop the AP, give bromocryptine (DA agonist)

26
Q

The tuberoinfundibular pathway

A

a population of dopamine neurons that project from the arcuate nucleus(a.k.a. the “ infundibular nucleus”) in the tuberal region of the hypothalamus to the median emminence It is one of the four major dopamine pathways in the brain. Dopamine released at this site inhibits the secretion of prolactin from anterior pituitary gland lactotrophs by binding to D2 receptors.
Some antipsychotic drugs block dopamine in the tuberoinfundibular pathway, which can cause an increase in the amount of prolactin in the blood

27
Q

The mesocortical pathway

A

a dopaminergic pathway that connects the ventral tegmentum to the prefrontal cortex. It is one of the four major dopamine pathways in the brain. It is essential to the normal cognitive function of the dorsolateral prefrontal cortex (part of the frontal lobe), and is thought to be involved in cognitive control, motivation and emotional response

28
Q

Positive symptoms

A

delusion, hallucination, loss of contact with reality, thought disorder (loose associations), disorganized thinking, paranoia, bizzare behaviour, verbal or physical aggression

29
Q

Negative symptoms

A

Bradyphrenia (reduced, poor thinking), blunted emotions, alogia (speechless, poverty of speech), anhedonia (absence of pleasure), ambivalence (mixed feelings), asociality (anti-social behaviours), decreased motivation, carelessness (poor social problem solving)

30
Q

Cognitive deficit

A

short-term memory impairement, long-term memory impairement, verbal memory impairement, attention impairement, reduced ability to abstract, reduced viligance

31
Q

Schizophrenia symptoms

A

The symptoms of schizophrenia are usually classified into: positive symptoms – any change in behaviour or thoughts, such as hallucinations or delusions. negative symptoms – where people appear to withdraw from the world around them, take no interest in everyday social interactions, and often appear emotionless and flat

32
Q

Schizophrenia

A

paranoid, catatonic, hebephrenia (disorganized)

33
Q

Affective psychoses

A

Bipolar disorders (type I and II) - manic phase is always considered psychotic, Major depression - only very severe cases are considred psychosis

34
Q

Other psychoses

A

Schizoaffective, Drug induced, Psychosis from organic reasons (e.g. dementia, Parkinson psychosis)

35
Q

Catatonia

A

a state in which someone is awake but does not seem to respond to other people and their environment

36
Q

Hebephrenia

A

a form of schizophrenia characterized especially by incoherence, delusions lacking an underlying theme, and affect that is usually flat, inappropriate, or silly
- delusions, hallucinations, disorganized speech and thoughts, disorganized or catatonic behavior, negative symptoms, such as an inability to show emotion or perform routine tasks.

37
Q

What is the best drug to treat negative symptoms of schizophrenia?

A

Cariprazine or Aripiprazole

note: Cariprazine is a distinctive AP agent due to its D3 preferential dopamine partial agonism, which makes it preferable with prominent negative symptoms

38
Q

Which symptoms is most unlikely to be caused by antipsychotic drugs?

A
  1. hypotension
  2. nausea
  3. Tradive dyskinesia
  4. EPS
  5. Weight gain
  6. Nausea

Pharma (86 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions